Latest Research for Eosinophilic Leukemia

Doctors are learning more about AML, ways to prevent it, the best way to treat it, and how to give the best care to people diagnosed with this disease. The following research areas may comprise new alternatives for patients with the help of clinical trials. Always talk with the doctor about the best diagnostic and treatment options for you.

  • Genetic research – Because this type of disorder is usually associated with a genetic mutation, researchers are searching for specific genes or mutations that can trigger eosinophilic leukaemia and could be targeted by new drugs.
  • Stem cell/bone marrow transplantation – New stem cell/bone marrow transplantation approaches are being tested to increase the use of this treatment option.
  • New treatments – Other combinations of chemotherapy and other treatments are being studied, as is the drug mepolizumab (Nucala). Early studies have shown that mepolizumab lowers eosinophils for people with allergies and HES. It has also helped control some symptoms and signs of HES.

Palliative care – Clinical trials are going on to find more acceptable ways of lessening symptoms and side effects of current cancer treatments to improve comfort and quality of life during treatment.